MaxCyte, Inc.
NASDAQ:MXCT
Overview | Financials
Company Name | MaxCyte, Inc. |
Symbol | MXCT |
Currency | USD |
Price | 3.86 |
Market Cap | 405,644,351 |
Dividend Yield | 0% |
52-week-range | 3.15 - 5.545 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Mr. Douglas Arthur Doerfler |
Website | https://maxcyte.com |
An error occurred while fetching data.
About MaxCyte, Inc.
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD